Authors

Latest:

Dr. Beddoe on the Impact of Cervical Cancer Screening

Ann Marie Beddoe, MD, assistant professor of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Hospital, discusses the impact of cervical cancer screening for women in the United States.

Ann McCue, RN, BSN, OCNÂ®

Latest:

Navigating Breast Cancer Survivorship: Sustaining the Good News

Forty years after the declaration of war on cancer, one of the most profound shifts in cancer care today is a new focus on treating those living beyond cancer, as well as those living with cancer.

Ann McMahon Wicker, PharmD, BCPS

Latest:

Clinical and Economic Considerations for the Use of Erythropoiesis-Stimulating Agents

Erythropoiesis-stimulating agents (ESAs) are genetically engineered forms of erythropoietin that stimulate erythropoiesis through direct or indirect action on the erythropoietin receptor producing an increase

Ann McNeill, RN, APN, JTCC&nbsp

Ann McNeill, RN, APN, JTCCÂ

Ann Ridgon, MSN, RN, OCN

Latest:

UVA Screening Program Seeks to Get Ahead of Colorectal Cancer

Approximately 1 of every 20 Americans will be diagnosed with colorectal cancer at some point in their life, and the American Cancer Society estimates that most colorectal cancer deaths can be prevented by screening.

Ann S. LaCasce, MD, MMSc

Latest:

Hodgkin Lymphoma: Overview and Update

Ann S. LaCasce, MD, MMSc, discusses updates in the Hodgkin lymphoma treatment paradigm.

Ann Tsao, MD, MD Anderson Cancer Center

Ann W. Silk, MD

Latest:

The Search for Immune-Specific Biomarkers Is in Full Swing

An improved understanding of how the immune system recognizes and eradicates cancer cells, along with advances in drugs that effectively promote antitumor immune responses, is revolutionizing the field of cancer therapy.

Anna Azvolinsky, PhD

Latest:

Evolving Role of Lymph Node Biopsies After Neoadjuvant Therapy for Breast Cancer

OncLive spoke with Kelly K. Hunt, MD, about how breast cancer interventions have progressed in the adjuvant and neoadjuvant setting and about the role of sentinel lymph node dissection in the neoadjuvant setting.

Anna Budina-Kolomets, MD

Latest:

Wistar-Penn Collaboration Identifies HSP70 as Promising New Target for Melanoma Therapy

A 10-year collaboration between scientists at The Wistar Institute and the University of Pennsylvania has recently resulted in the emergence of an exciting new target for cancer therapy, heat shock protein 70, that could be helpful in treating patients with melanoma.

Anna C. Ferrari, MD

Latest:

Dr. Ferrari on LBH589 and Bicalutamide in CRPC

Anna C. Ferrari, MD, professor, co-director, GU Research Program, Departments of Medicine (Cancer Center) and Medicine (Residency Program), discusses a study that examined the efficacy of LBH589 and bicalutamide in patients with castration-resistant prostate cancer.

Anna C. Pavlick, DO

Latest:

Closing Thoughts on Intralesional Therapy for Melanoma and CSCC

A panel of skin cancer experts offer closing thoughts on intralesional therapy for treating melanoma and CSCC.

Anna C. Pavlick, DO, NYU Langone Hospitals

Anna F. Farago, MD, PhD

Latest:

Dr. Farago on Frontline Immunotherapy Versus Maintenance Immunotherapy in SCLC

Anna F. Farago, MD, PhD, medical oncologist at the Center for Thoracic Cancers at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, discusses the use of frontline immunotherapy versus maintenance immunotherapy in patients with small cell lung cancer (SCLC).

Anna Farago, MD, PhD

Latest:

Dr. Farago on Opportunities to Investigate Biomarkers for Small Cell Lung Cancer

Anna Farago, MD, PhD, Massachusetts General Hospital Cancer Center, instructor of Medicine at Harvard Medical School, discusses opportunities for the development of biomarkers for patients with small cell lung cancer (SCLC).

Anna Kaminsky, DO

Latest:

Palliative Care: Let’s Keep the Conversation Open

As the end of my hematology/oncology fellowship draws near, I am reminded every day that oncology is not about winning or losing.

Anna Maria Storniolo, MD

Latest:

The Goodwill of Strangers Helps Build a Unique Resource for Cancer Research

Thousands of women have made the selfless choice to literally donate a precious piece of themselves by giving a breast tissue sample to the Susan G. Komen Tissue Bank at the Indiana University Melvin and Bren Simon Cancer Center, a unique resource for researchers worldwide.

Anna Vioral, MSN, MEd, RN, OCN

Latest:

Anna Vioral on Multidisciplinary Chemotherapy Safety Standards

Anna Vioral, RN, OCN, from West Penn Allegheny Health System, on Multidisciplinary Chemotherapy Safety Standards.

Anne Chiang, MD

Latest:

Chiang Contextualizes the Optimal Use of Lurbinectedin in SCLC Management

Dr Chiang discusses the use of lurbinectedin in small cell lung cancer and tips for managing toxicities associated with this agent.